Table 2.
The major outcomes of two period's groups.
| Eradication rate |
|||
|---|---|---|---|
| Group A (n = 90) | Group B (n = 93) | p-value | |
| Intention-to-treata | 87.8% (86/98) | 84.8% (84/99) | 0.55 |
| Per-protocol | 95.6% (86/90) | 90.3% (84/93) | 0.17 |
| Adverse events | 16.7% (15/90) | 10.8% (10/93) | 0.24 |
| Compliance | 100% (90/90) | 100% (93/93) | – |
The eradication rates for Group A and Group B were 87.8% (95% confidence interval [CI] = 79.64%–93.54%) and 84.8% (95% CI = 76.19%–91.23%) (p = 0.553) in intention-to-treat (ITT) analysis; 95.6% (95% CI = 89.07%–98.80%) and 90.3%(95% CI = 82.40%–95.46%) (p = 0.168) in per protocol (PP) analysis.
a
In this analysis, patients with unknown outcome are counted as treatment failures.